A detailed history of Parallel Advisors, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 61 shares of SRRK stock, worth $2,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 61 -0.0%
Holding current value
$2,681
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $367 - $473
61 New
61 $0
Q4 2021

Jan 20, 2022

SELL
$24.14 - $35.18 $458 - $668
-19 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$27.38 - $42.21 $520 - $801
19 New
19 $1,000
Q2 2021

Aug 06, 2021

SELL
$26.34 - $46.62 $553 - $979
-21 Closed
0 $0
Q1 2021

Apr 23, 2021

BUY
$45.96 - $68.02 $965 - $1,428
21 New
21 $1,000
Q2 2020

Jul 16, 2020

SELL
$10.37 - $20.64 $5,330 - $10,608
-514 Closed
0 $0
Q1 2020

Apr 27, 2020

BUY
$9.63 - $17.14 $4,949 - $8,809
514 New
514 $6,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.27B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.